课题基金 / 基金详情

Analysis of elimination of non-self and development of Stealth T cells aiming generalized antigen-specific adoptive T cell therapy

Analysis of elimination of non-self and development of Stealth T cells aiming generalized antigen-specific adoptive T cell therapy
针对广义抗原特异性过继性T细胞治疗的非自身消除及隐形T细胞开发分析
批准号:
15H04918
负责人:
IKEDA Hiroaki
金额:
$10.82万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2015
资助国家:
日本
项目状态:
已结题
起止时间:
2015-04-01 至 2018-03-31

项目摘要

项目成果

IKEDA Hiroaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1038/ncomms14607
发表时间: 2017-02-24
期刊: Nature communications
影响因子: 16.6
作者: [Takeda K, Nakayama M, Hayakawa Y, Kojima Y, Ikeda H, Imai N, Ogasawara K, Okumura K, Thomas DM, Smyth MJ]
通讯作者: Smyth MJ
Tumor-Specific Donor Lymphocyte Infusion for Tumor Relapse after MHC-Haploidentical Hematopoietic Stem Cell Transplantation
肿瘤特异性供体淋巴细胞输注治疗 MHC 单倍体相合造血干细胞移植后肿瘤复发
DOI: --
发表时间: 2016
期刊:
影响因子: --
作者: [Isao Tawara, Kana Okamori, Naoyuki Katayama, Hiroshi Shiku, Hiroaki Ikeda.]
通讯作者: Hiroaki Ikeda.
Development of immunotherapy with chimeric antigen receptor targeting intracellular WT1 gene product presented on HLA-A*24:02 molecule
开发针对 HLA-A*24:02 分子上呈递的细胞内 WT1 基因产物的嵌合抗原受体免疫疗法
DOI: --
发表时间: 2015
期刊:
影响因子: --
作者: [Yasushi Akahori, Motohiro Yoneyama, Hiroaki Ikeda, Yuki Orito, Yoshihiro Miyahara, Yasunori Amaishi, Sachiko Okamoto, Junichi Mineno, Kazutoh Takesako, Hiroshi Fujiwara, Masaki Yasukawa, Hiroshi Shiku]
通讯作者: Hiroshi Fujiwara, Masaki Yasukawa, Hiroshi Shiku
Personalized Medicineとしてのがん免疫療法、 遺伝子医学MOOK31 がん免疫療法
癌症免疫治疗作为个体化医疗、基因医学 MOOK31 癌症免疫治疗
DOI: --
发表时间: 2017
期刊:
影响因子: --
作者: [Sugimachi K, Nishio M, Aishima S, Kuroda Y, Iguchi T, Komatsu H, Hirata H, Sakimura S, Eguchi H, Bekki Y, Takenaka K, Maehara Y, Suzuki A, Mimori K., 池田裕明]
通讯作者: 池田裕明
45
    Personalized cancer immunotherapy of gastrointestinal tumors based on identification of neoantigens and reverting of immunosuppression
    • 批准号:
      18K19584
    • 项目类别:
      Grant-in-Aid for Challenging Research (Exploratory)
    • 资助金额:
      $4.08万
    • 财政年份:
      2018
    • 负责人:
      IKEDA Hiroaki
    • 依托单位:
    Development of cell therapy for patients with tumors utilizing allogeneic stealth T cells
    • 批准号:
      18H02872
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.23万
    • 财政年份:
      2018
    • 负责人:
      IKEDA Hiroaki
    • 依托单位:
    Interplay between spin-orbit interaction and electron correlation --- analysis based on the first-principles calculations
    Identification of factors that determine the fate of functional T cells in vivo and development of effective TCR gene-modified T cell therapy
    • 批准号:
      24390300
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.81万
    • 财政年份:
      2012
    • 负责人:
      IKEDA Hiroaki
    • 依托单位:
    海外基金